Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated February 03, 2026, titled “SPARC Announces Receipt of Priority Review Voucher associated with Sezaby® Approval”. |SUBJECT: Press Release
Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated February 03, 2026, titled “SPARC Announces Receipt of Priority Review Voucher associated with Sezaby® Approval”. |SUBJECT: Press Release